Company profile: Medaspis
1.1 - Company Overview
Company description
- Provider of professional expertise in healthcare, pharmaceuticals, IT, and logistics, backed by long-standing experience across these fields.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Medaspis
Enavate Sciences
HQ: United States
Website
- Description: Provider of capital and strategic growth support to therapeutic and enabling technology companies, partnering with life sciences companies and their investors to advance and accelerate the development of novel therapies and help companies realize their potential.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enavate Sciences company profile →
Tetris Pharma
HQ: United Kingdom
Website
- Description: Provider of a pan-European platform to market a range of prescription products, offered by a UK-based speciality pharmaceutical company with extensive experience of launching products in the UK and across Europe, focused on areas of unmet clinical need.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tetris Pharma company profile →
Aragen Bioscience
HQ: United States
Website
- Description: Provider of preclinical contract research and development services specializing in recombinant cell line and hybridoma development, cell culture and protein purification process development and production, mammalian protein expression, primary and immortalized cell-based assays, in vivo models of human disease, custom immunological services, preclinical efficacy studies, and vivarium-based rodent studies including BSL-2 suites.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aragen Bioscience company profile →
Suanfarma
HQ: Spain
Website
- Description: Provider of development, manufacturing, and distribution of raw materials and finished dosage forms for pharmaceutical, biotechnological, veterinary, nutritional, and cosmetic sectors. Offers human and veterinary APIs and generics across multiple therapeutic areas, CDMO services for fermentation and chemical synthesis under cGMP, predictive maintenance, and R&D on alternative synthesis routes and analytical methods.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Suanfarma company profile →
LifeTec
HQ: The Netherlands
Website
- Description: Provider of pre-clinical contract research and biosimulation solutions for medical device innovation, offering BioSimulator platforms and culture systems for R&D and hands-on clinical training, available for lease or purchase; preclinical research services without live animal models; and prototyping, device development, and manufacturing via Resolution Medical, including BioLiver, Cardiac, and OsteoChondral platforms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LifeTec company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Medaspis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Medaspis
2.2 - Growth funds investing in similar companies to Medaspis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Medaspis
4.2 - Public trading comparable groups for Medaspis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →